Interactions of cytokines, S‐adenosylmethionine, and S‐adenosylhomocysteine in alcohol‐induced liver disease and immune suppression
- 22 August 2006
- journal article
- review article
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 21 (s3) , S38-S42
Abstract
Alcoholic liver disease (ALD) remains a leading cause of death in the USA. Defining mechanisms for liver cell death in ALD in order to develop potential new agents for therapeutic intervention is a major focus of the authors’ work. Abnormal cytokine metabolism is a major feature of ALD, and a thorough understanding of both mechanisms and interactions of cytokine overproduction and sensitization are critical to developing a possible treatment for ALD. S‐Adenosylmethionine has been used in a variety of animal studies and clinical trials and has been reported to improve biochemical parameters of liver function. Last, immunosuppression associated with chronic alcohol abuse is an important predisposing factor to opportunistic infections and cancer. It is the authors’ working hypothesis that alcohol consumption leads to chronic activation of the immune system.Keywords
This publication has 27 references indexed in Scilit:
- S-adenosylmethionine (SAMe) modulates interleukin-10 and interleukin-6, but not TNF, production via the adenosine (A2) receptorBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2005
- S-adenosylhomocysteine sensitizes to TNF-α hepatotoxicity in mice and liver cells: A possible etiological factor in alcoholic liver diseaseHepatology, 2004
- Identification of the human mitochondrial S-adenosylmethionine transporter: bacterial expression, reconstitution, functional characterization and tissue distributionBiochemical Journal, 2004
- Abnormal Hepatic Methionine and Glutathione Metabolism in Patients With Alcoholic HepatitisAlcohol, Clinical and Experimental Research, 2004
- Inhibition of Proteasome Function Leads to Nf–κB–Independent Il–8 Expression in Human HepatocytesHepatology, 2003
- S-Adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trialJournal of Hepatology, 1999
- Association of a tumor necrosis factor promoter polymorphism with susceptibility to alcoholic steatohepatitisHepatology, 1997
- In vitro tumor necrosis factor cytotoxicity in HEP G2 liver cellsHepatology, 1995
- Hepatic Phosphatidylethanolamine Methyltransferase Activity Is Decreased by Ethanol and Increased by PhosphatidylcholineAlcohol, Clinical and Experimental Research, 1994
- S –Adenosyl–L–Methionine Attenuates Alcohol–Induced Liver Injury in the BaboonHepatology, 1990